Cornel Iridoid Glycoside Inhibits Tau Hyperphosphorylation via Regulating Cross-Talk Between GSK-3β and PP2A Signaling

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

Vivanco, I., & Sawyers, C. L. (2002) · Nature reviews. Cancer · doi:10.1038/nrc839 · Cited by 6,041 · see citing works

Neurodegenerative Tauopathies

Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · see citing works

Alzheimer’s Disease: The Challenge of the Second Century

Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424 · see citing works

Molecular cloning and expression of glycogen synthase kinase‐3/factor A.

Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362 · see citing works

Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration

Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L.-L., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.030 · Cited by 1,118 · see citing works

Tau phosphorylation: the therapeutic challenge for neurodegenerative disease

Hanger, D. P., Anderton, B. H., & Noble, W. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.003 · Cited by 965 · see citing works

Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics

Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774 · see citing works

Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation

Liu, F., Grundke‐Iqbal, I., Iqbal, K., & Gong, C. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04391.x · Cited by 759 · see citing works

Wortmannin Inactivates Phosphoinositide 3-Kinase by Covalent Modification of Lys-802, a Residue Involved in the Phosphate Transfer Reaction

Wymann, M. P., Bulgarelli-Leva, G., Zvelebil, M., Pirola, L., Vanhaesebroeck, B., Waterfield, M. D., & Panayotou, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1722 · Cited by 679 · see citing works

Phosphoprotein Phosphatase Activities in Alzheimer Disease Brain

Gong, C., Singh, T. J., Grundke‐Iqbal, I., & Iqbal, K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03603.x · Cited by 527 · see citing works

Protein phosphatase 2A regulatory subunits and cancer

Eichhorn, P. J. A., Creyghton, M. P., & Bernards, R. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.05.005 · Cited by 513 · see citing works

Structure and Pathology of Tau Protein in Alzheimer Disease

Kolarova, M., García‐Sierra, F., Bartoš, A., Říčný, J., & Řı́pová, D. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/731526 · Cited by 473 · see citing works

The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy

McGeer, P. L., & McGeer, E. G. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1177-7 · Cited by 467 · see citing works

Phosphatase Activity Toward Abnormally Phosphorylated τ: Decrease in Alzheimer Disease Brain

Gong, C., Shaikh, S., Wang, J., Zaidi, T., Grundke, I., & Iqbal, K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020732.x · Cited by 440 · see citing works

Distribution, Levels, and Activity of Glycogen Synthase Kinase-3 in the Alzheimer Disease Brain

PEI, J.-J., TANAKA, T., TUNG, Y.-C., BRAAK, E., IQBAL, K., & GRUNDKE-IQBAL, I. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199701000-00007 · Cited by 371 · see citing works

Clinicopathologic and¹¹C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum

Murray, M. E., Lowe, V. J., Graff-Radford, N. R., Liesinger, A. M., Cannon, A., Przybelski, S. A., Rawal, B., Parisi, J. E., Petersen, R. C., Kantarci, K., et al. (2015) · Brain · doi:10.1093/brain/awv050 · Cited by 324 · see citing works

PP2A mRNA Expression Is Quantitatively Decreased in Alzheimer's Disease Hippocampus

Vogelsberg-Ragaglia, V., Schuck, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7630 · Cited by 281 · see citing works

Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer’s disease

Kitagishi, Y., Nakanishi, A., Ogura, Y., & Matsuda, S. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt265 · Cited by 246 · see citing works

Has the amyloid cascade hypothesis for Alzheimer's disease been proved?

Hardy, J. (2006) · Current Alzheimer Research · doi:10.2174/156720506775697098 · Cited by 242 · see citing works

Altered Expression Levels of the Protein Phosphatase 2A ABαC Enzyme Are Associated with Alzheimer Disease Pathology

Sontag, E., Luangpirom, A., Hladik, C., Mudrak, I., Ogris, E., Speciale, S., & White, C. L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.4.287 · Cited by 228 · see citing works

AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation

Li, X., Lv, B.-L., Xie, J., Liu, J., Zhou, X., & Wang, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.003 · Cited by 207 · see citing works

Structural mechanism of demethylation and inactivation of protein phosphatase 2A

Xing, Y., Li, Z., Chen, Y., Stock, J. B., Jeffrey, P. D., & Shi, Y. (2008) · Cell · doi:10.1016/j.cell.2008.02.041 · Cited by 206 · see citing works

Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK‐3β

Liu, F., Iqbal, K., Grundke, I., & Gong, C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03487-7 · Cited by 197 · see citing works

Downregulation of Protein Phosphatase 2A Carboxyl Methylation and Methyltransferase May Contribute to Alzheimer Disease Pathogenesis

Sontag, E., Hladik, C. L., Montgomery, L. G., Luangpirom, A., Mudrak, I., Ogris, E., & White, C. L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.10.1080 · Cited by 191 · see citing works

The active form of glycogen synthase kinase-3? is associated with granulovacuolar degeneration in neurons in Alzheimer's disease

Boutajangout, A., Leroy, K., Authelet, M., Anderton, B. H., Brion, J., & Woodgett, J. R. (2002) · Acta Neuropathologica · doi:10.1007/s004010100435 · Cited by 186 · see citing works

Carboxyl methylation of the phosphoprotein phosphatase 2A catalytic subunit promotes its functional association with regulatory subunits in vivo

Wu, J., Tolstykh, T., Lee, J., Boyd, K., Stock, J. B., & Broach, J. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5672 · Cited by 186 · see citing works

PP2A Regulates Tau Phosphorylation Directly and also Indirectly via Activating GSK-3β

Qian, W., Shi, J., Yin, X., Iqbal, K., Grundke-Iqbal, I., Gong, C., & Liu, F. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1317 · Cited by 185 · see citing works

Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus

Zhang, C.-E., Tian, Q., Wei, W., Peng, J.-H., Liu, G., Zhou, X., Wang, Q., Wang, D. W., & Wang, J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.015 · Cited by 159 · see citing works

The structural basis for tight control of PP2A methylation and function by LCMT-1

Stanevich, V., Jiang, L., Satyshur, K. A., Li, Y., Jeffrey, P. D., Li, Z., Menden, P., Semmelhack, M. F., & Xing, Y. (2011) · Molecular Cell · doi:10.1016/j.molcel.2010.12.030 · Cited by 142 · see citing works

Synaptic Released Zinc Promotes Tau Hyperphosphorylation by Inhibition of Protein Phosphatase 2A (PP2A)

Sun, X., Wei, Y., Xiong, Y., Wang, X., Xie, A., Wang, X., Yang, Y., Wang, Q., Lu, Y., Liu, R., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.309070 · Cited by 137 · see citing works

Cross talk between PI3K-AKT-GSK-3β and PP2A pathways determines tau hyperphosphorylation

Wang, Y., Yang, R., Gu, J., Yin, X., Jin, N., Xie, S., Wang, Y., Chang, H., Qian, W., Shi, J., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.035 · Cited by 134 · see citing works

Phosphoprotein Phosphatase 2A: A Novel Druggable Target for Alzheimer’s Disease

Voronkov, M. V., Braithwaite, S. P., & Stock, J. B. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.47 · Cited by 121 · see citing works

Cornel iridoid glycoside promotes neurogenesis and angiogenesis and improves neurological function after focal cerebral ischemia in rats

Yao, R., Zhang, L., Wang, W., & Li, L. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.12.010 · Cited by 103 · see citing works

An inactive protein phosphatase 2A population is associated with methylesterase and can be re-activated by the phosphotyrosyl phosphatase activator

Longin, S., Jordens, J., MARTENS, E., Stevens, I., Janssens, V., Rondelez, E., BAERE, I. D., Derua, R., Waelkens, E., Goris, J., et al. (2004) · Biochemical Journal · doi:10.1042/bj20031643 · Cited by 101 · see citing works

Structure of Protein Phosphatase Methyltransferase 1 (PPM1), a Leucine Carboxyl Methyltransferase Involved in the Regulation of Protein Phosphatase 2A Activity

Leulliot, N., Quevillon‐Chéruel, S., Sorel, I., de la Sierra-Gallay, I. L., Collinet, B., Graille, M., Blondeau, K., Bettache, N., Anne Poupon, B., Janin, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311484200 · Cited by 86 · see citing works

In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors

Sarno, P. D., Bijur, G. N., Zmijewska, A. A., Li, X., & Jope, R. S. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.003 · Cited by 81 · see citing works

Folate Deficiency Induces In Vitro and Mouse Brain Region-Specific Downregulation of Leucine Carboxyl Methyltransferase-1 and Protein Phosphatase 2A Bα Subunit Expression That Correlate with Enhanced Tau Phosphorylation

Sontag, J., Nunbhakdi‐Craig, V., Montgomery, L. G., Arning, E., Bottiglieri, T., & Sontag, E. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2816-08.2008 · Cited by 77 · see citing works

Activation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in culture

Li, X.-C., Lu, F., Tian, Q., Yang, Y., Wang, Q., & Wang, J.-H. (2005) · Journal of neural transmission · doi:10.1007/s00702-005-0303-7 · Cited by 70 · see citing works

Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3β

Martin, L., Page, G., & Terro, F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.05.010 · Cited by 65 · see citing works

Inhibition of protein phosphatase 2A induces phosphorylation and accumulation of neurofilaments in metabolically active rat brain slices

Gong, C., Wang, J., Iqbal, K., & Grundke, I. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00096-x · Cited by 64 · see citing works

Intercellular transfer of tau aggregates and spreading of tau pathology: Implications for therapeutic strategies

Clavaguera, F., Grueninger, F., & Tolnay, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.037 · Cited by 60 · see citing works

Injection of okadaic acid into the meynert nucleus basalis of rat brain induces decreased acetylcholine level and spatial memory deficit

Tian, Q., Lin, Z.-Q., Wang, X., Chen, J., Wang, Q., Gong, C., & Wang, J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.037 · Cited by 57 · see citing works

Cornel iridoid glycoside improves memory ability and promotes neuronal survival in fimbria–fornix transected rats

Zhao, L.-H., Ding, Y., Zhang, L., & Li, L. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.08.016 · Cited by 57 · see citing works

Leucine carboxyl methyltransferase 1 (LCMT-1) methylates protein phosphatase 4 (PP4) and protein phosphatase 6 (PP6) and differentially regulates the stable formation of different PP4 holoenzymes

Hwang, J., Lee, J. A., & Pallas, D. C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.739920 · Cited by 56 · see citing works

Regulation of protein phosphatase 2A (PP2A) tumor suppressor function by PME-1

Kaur, A., & Westermarck, J. K. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160161 · Cited by 53 · see citing works

PP1/PP2A phosphatases inhibitors okadaic acid and calyculin A block ERK5 activation by growth factors and oxidative stress

Garcia, L., Garcia, F., Llorens, F., Unzeta, M., Itarte, E., & Gómez, N. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02950-2 · Cited by 48 · see citing works

Immunological memory to hyperphosphorylated tau in asymptomatic individuals

Pascual, G., Wadia, J. S., Zhu, X., Keogh, E. A., Kaletaş, B. K., van Ameijde, J., Inganäs, H., Siregar, B., Perdok, G. J., Diefenbach, O., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1705-y · Cited by 44 · see citing works

GSK-3β and memory formation

Takashima, A. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00047 · Cited by 38 · see citing works

Glycogen synthase kinase‐3β regulates leucine‐309 demethylation of protein phosphatase‐2A via PPMT1 and PME‐1

Yao, X., Li, X., Zhang, X., Yin, Y., Liu, B., Luo, D., Wang, Q., Wang, J., & Liu, G. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.06.018 · Cited by 37 · see citing works

PRMT8 Controls the Pluripotency and Mesodermal Fate of Human Embryonic Stem Cells By Enhancing the PI3K/AKT/SOX2 Axis

Jeong, H.-C., Park, S.-J., Choi, J.-J., Go, Y., Hong, S.-K., Kwon, O.-S., Shin, J.-G., Kim, R., Lee, M.-O., Lee, S.-J., et al. (2017) · Stem Cells · doi:10.1002/stem.2642 · Cited by 35 · see citing works

Protein Phosphatase Methyltransferase 1 (Ppm1p) Is the Sole Activity Responsible for Modification of the Major Forms of Protein Phosphatase 2A in Yeast

Kalhor, H. R., Luk, K., Ramos, A., Zobel-Thropp, P. A., & Clarke, S. G. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2558 · Cited by 29 · see citing works

Okadaic acid is taken-up into the cells mediated by human hepatocytes transporter OATP1B3

Ikema, S., Takumi, S., Maeda, Y., et al. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.06.006 · Cited by 23 · see citing works

Cornel Iridoid Glycoside Attenuates Tau Hyperphosphorylation by Inhibition of PP2A Demethylation

Yang, C., Kuai, X.-X., Li, Y., Zhang, L., Yu, J., Li, L., & Zhang, L. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/108486 · Cited by 23 · see citing works

Small-molecule GSK-3 inhibitor rescued apoptosis and neurodegeneration in anesthetics-injured dorsal root ganglion neurons

Tian-chao, Y., & Lin, W. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.08.059 · Cited by 20 · see citing works

Beneficial effects of cornel iridoid glycoside on behavioral impairment and senescence status in SAMP8 mice at different ages

Ma, D., Zhu, Y., Li, Y., Yang, C., Zhang, L., Li, Y., Li, L., & Zhang, L. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.008 · Cited by 18 · see citing works

S-phase arrest by reactive nitrogen species is bypassed by okadaic acid, an inhibitor of protein phosphatases PP1/PP2A

Ranjan, P., & Heintz, N. H. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.049 · Cited by 17 · see citing works

[Hepatoprotective effects of extracts from processed corni fructus against D-galactose-induced liver injury in mice].

Jiang, Z., Li, Y., Jiang, L., et al. (2013) · PubMed · Cited by 17 · see citing works

Inhibition of Protein Phosphatase 2A: Focus on the Glutamatergic System

Zimmer, E. R., Leuzy, A., Souza, D. O., & Portela, L. V. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9321-0 · Cited by 10 · see citing works

Small molecule therapeutics for tauopathy in Alzheimer’s disease: Walking on the path of most resistance

Wang, L., Bharti, Kumar, R., Pavlov, P. F., & Winblad, B. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112915 · Cited by 92 · see citing works

Role of Tau Protein in Neurodegenerative Diseases and Development of Its Targeted Drugs: A Literature Review

Yang, J., Zhi, W., & Wang, L. (2024) · Molecules · doi:10.3390/molecules29122812 · Cited by 63 · see citing works

Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration

Yang, C., Kuai, X.-X., Gao, W., Yu, J., Wang, Q., Li, L., & Zhang, L. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150728 · Cited by 34 · see citing works

Cross talk between PI3K-AKT-GSK-3β and PP2A pathways determines tau hyperphosphorylation

Wang, Y., Yang, R., Gu, J., Yin, X., Jin, N., Xie, S., Wang, Y., Chang, H., Qian, W., Shi, J., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.035 · Cited by 134 · see citing works

Effect of GSK-3 overactivation on neurofilament phosphorylation

Chen, J., Jie, Z., Youmei, F., et al. (2005) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/bf02828200 · Cited by 7 · see citing works

Inhibition of Glycogen Synthase Kinase-3 Reverses Tau Hyperphosphorylation Induced by Pin1 Down-Regulation

Xiong, Y., Wang, D., Tan, L., et al. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312030016 · Cited by 10 · see citing works

Upstream Mechanisms of Glycogen Synthase Activation by Insulin and Insulin-like Growth Factor-I

Yamamoto‐Honda, R., Tobe, K., Kaburagi, Y., Ueki, K., Asai, S., Yachi, M., Shirouzu, M., Yodoi, J., Akanuma, Y., Yokoyama, S., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2729 · Cited by 109 · see citing works